Oncocross Market Cap

Oncocross has a market cap or net worth of 156.16 billion as of June 27, 2025.

Market Cap

156.16B

Enterprise Value

139.58B

Revenue

1.07B

Ranking

n/a

PE Ratio

n/a

Stock Price

11,420.00

Market Cap Chart

Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 156.16B, an increase of 46.98%. That is a compound annual growth rate of 108.75%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	136.45B	81.49%
Dec 30, 2024	75.18B	-29.24%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.89T
ALTEOGEN	20.33T
Yuhan	7,706.69B
SK Biopharmaceuticals	7,126.51B
HLB Co., Ltd.	6,270.01B
Peptron	4,775.96B
PharmaResearch	4,488.33B

Market Cap Rankings